Class I

Drug Recall: Umary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets, packaged in 30-count bottles.

MAIN PRODUCTS INC · July 18, 2024

Reason for Recall

Marketed without Approved NDA/ANDA. FDA analysis found product to be tainted with undeclared Diclofenac and Omeprazole.

Distribution

Nationwide within the U.S

States Affected

NATIONWIDE

Quantity Affected

57, 340 bottles

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0626-2024

Status: ongoing

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.

MAIN PRODUCTS INC Drug Recall: Umary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets, packaged in 30-count bottles. | SafeCheck